DK1765859T3 - Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf - Google Patents

Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf

Info

Publication number
DK1765859T3
DK1765859T3 DK05766056.5T DK05766056T DK1765859T3 DK 1765859 T3 DK1765859 T3 DK 1765859T3 DK 05766056 T DK05766056 T DK 05766056T DK 1765859 T3 DK1765859 T3 DK 1765859T3
Authority
DK
Denmark
Prior art keywords
annexins
annexin
therapeutic
derivatives
well
Prior art date
Application number
DK05766056.5T
Other languages
English (en)
Inventor
Chris Reutelingsperger
Original Assignee
Mosamedix Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosamedix Bv filed Critical Mosamedix Bv
Application granted granted Critical
Publication of DK1765859T3 publication Critical patent/DK1765859T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK05766056.5T 2004-07-07 2005-07-06 Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf DK1765859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/886,262 US7511016B2 (en) 2004-07-07 2004-07-07 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
PCT/IB2005/001922 WO2006003488A2 (en) 2004-07-07 2005-07-06 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof

Publications (1)

Publication Number Publication Date
DK1765859T3 true DK1765859T3 (da) 2014-10-27

Family

ID=35542135

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05766056.5T DK1765859T3 (da) 2004-07-07 2005-07-06 Annexiner, derivater deraf og annexin-cys varianter samt terapeutiske og diagnostiske anvendelser deraf

Country Status (7)

Country Link
US (1) US7511016B2 (da)
EP (1) EP1765859B1 (da)
AU (1) AU2005258899A1 (da)
CA (1) CA2572707C (da)
DK (1) DK1765859T3 (da)
ES (1) ES2500340T3 (da)
WO (1) WO2006003488A2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1756572B1 (en) * 2004-05-13 2016-02-24 Centre National De La Recherche Scientifique (Cnrs) A device for binding a target entity to a bait entity and detection methods using the same
DK1960790T3 (da) * 2005-12-12 2017-03-06 Mosamedix Bv Annexinderivater, der er egnede til prætargetering ved behandling og diagnose
WO2007112403A2 (en) * 2006-03-27 2007-10-04 The Regents Of The University Of Colorado Prevention and treatment of ischemia-reperfusion injury
CA2669398C (en) * 2006-11-13 2016-01-05 Perkinelmer Las, Inc. Detecting molecular interactions comprising a target-selective binding agent and a target molecule with fluorescence resonance energy transfer (fret)
US8846053B2 (en) 2008-09-26 2014-09-30 Sdg, Inc. Orally bioavailable lipid-based constructs
US20100080773A1 (en) 2008-09-26 2010-04-01 Sdg, Inc. Orally Bioavailable Lipid-Based Constructs
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
SI2234631T1 (sl) 2007-12-18 2013-02-28 Athera Biotechnologies Ab Spojine in postopki za zdravljenje ĺ˝ilne bolezni
GB0905348D0 (en) * 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US8377881B2 (en) 2008-04-01 2013-02-19 MosaMedix B. V. Compositions and methods for reducing scar formation in wound healing
WO2009124135A2 (en) * 2008-04-01 2009-10-08 University Of Southern California Annexin-based apoptosis markers
US8747808B2 (en) * 2008-08-26 2014-06-10 Mosamedix B.V. Radiolabeled annexins
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
CA2764029C (en) * 2009-06-03 2019-10-29 Mosamedix B.V. Method for enhancing phagocytosis of phosphatidylserine-exposing cells
ES2674567T3 (es) 2010-05-21 2018-07-02 Merrimack Pharmaceuticals, Inc. Proteínas de fusión biespecíficas
JP6471385B2 (ja) 2013-03-15 2019-02-20 グラディエーター・バイオサイエンシーズ・インコーポレイテッド 標的化剤としてのＧｌａドメイン
CN106029363B (zh) 2014-02-13 2018-01-16 3M创新有限公司 双重固化耐污微球体制品
JP2018507227A (ja) 2015-03-03 2018-03-15 キュアポート インコーポレイテッド 二薬搭載リポソーム医薬製剤
EP3265059A4 (en) 2015-03-03 2018-08-29 Cureport Inc. Combination liposomal pharmaceutical formulations
GB2542391A (en) * 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture
CA3000742A1 (en) 2015-10-02 2017-04-06 Silver Creek Pharmaceuticals, Inc. Bi-specific therapeutic proteins for tissue repair
SG11201908052PA (en) 2017-03-13 2019-09-27 Sdg Inc Lipid-based nanoparticles with enhanced stability
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
PE20201462A1 (es) 2017-09-05 2020-12-17 Gladiator Biosciences Inc Metodo de direccionamiento de exosomas
EP3692984A1 (en) * 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexin-coated particles
CN118512400A (zh) * 2024-05-17 2024-08-20 国家纳米科学中心 膜联蛋白在提高具有磷脂表面的纳米载体入瘤效率中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166322A (en) * 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
US5834196A (en) 1994-04-11 1998-11-10 Nexins Research B.V. Method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
ES2398118T3 (es) 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
AU750414B2 (en) * 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
WO2000010673A1 (en) 1998-08-24 2000-03-02 Nst Neurosurvival Technologies Ltd. Apparatus and method for capturing particles with surface exposure of anionic phospholipids from biological fluids
US6323313B1 (en) 1999-06-01 2001-11-27 The University Of Washington Annexin derivative with endogenous chelation sites
US20020083888A1 (en) * 2000-12-28 2002-07-04 Zehnder Donald A. Flow synthesis of quantum dot nanocrystals
WO2002077011A2 (en) * 2001-03-12 2002-10-03 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Oxidation-reduction sensitive green fluorescent protein variants
US20020192721A1 (en) * 2001-03-28 2002-12-19 Engeneos, Inc. Modular molecular clasps and uses thereof
US6843980B2 (en) * 2001-04-03 2005-01-18 Theseus Imaging, Corp. Methods for using annexin for detecting cell death in vivo and treating associated conditions
CA2486362A1 (en) 2002-06-06 2003-12-18 Tze Chein Wun Novel recombinant anticoagulant proteins

Also Published As

Publication number Publication date
CA2572707C (en) 2014-08-19
US7511016B2 (en) 2009-03-31
ES2500340T3 (es) 2014-09-30
EP1765859B1 (en) 2014-07-30
US20060009381A1 (en) 2006-01-12
WO2006003488A2 (en) 2006-01-12
AU2005258899A1 (en) 2006-01-12
WO2006003488A3 (en) 2006-05-04
CA2572707A1 (en) 2006-01-12
EP1765859A2 (en) 2007-03-28

Similar Documents

Publication Publication Date Title
ATE525088T1 (de) Kombinationstherapie
EP1868459A4 (en) FUNCTIONAL SHOE
DE502005007353D1 (de) Zervikale zwischenwirbelprothese
EP1962961A4 (en) HALF-BODY: THERAPEUTIC AGENTS ACTIVATED BY DIMÉRIZATION
DE60315135D1 (de) Therapiesonde
EE200500035A (et) Personaalne teraapiasektsioon
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK1959991T3 (da) Terapeutisk vaccine
PL3424932T3 (pl) Boronoftalidy do zastosowania terapeutycznego
DK2609947T3 (da) Plasterlignende infusionsapparat
DK1863899T3 (da) Hudbehandlingspræparater
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1597171T3 (da) Terapeutisk mikroskum
DK2119472T3 (da) Hud-/hårbehandlingssystem
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
DE602006004713D1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
NL1026326A1 (nl) Patient-ligtafel.
DE602004003978D1 (de) Verbinder
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
ATE460415T1 (de) Therapeutische pyrazoloä3,4-büpyridine und - indazole
DK1940840T3 (da) 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf
ES1058102Y (es) Lentilla terapeutica.
NO20053189D0 (no) HVC-kombinasjonsterapi.
ITRM20030283A1 (it) Mezzi terapeutici e diagnostici per i papillomi.